Reata Pharma (RETA) reported Q3 EPS of ($1.47), $0.74 better than the analyst estimate of ($2.21). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1.03 million.
Reata Pharma (RETA) reported Q3 EPS of ($1.47), $0.74 better than the analyst estimate of ($2.21). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1.03 million.